Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VRAXVirax Biolabs Group Ltd

Nasdaq · CIK 0001885827
Filer categoryNon-accelerated filer<br>Emerging growth company
Entity typeother
SIC2835 In Vitro & In Vivo Diagnostic Substances
FY end0331
XBRL facts128

Identity from submissions API

NameVirax Biolabs Group Ltd
CIK0001885827
TickersVRAX
ExchangesNasdaq
Entity typeother
CategoryNon-accelerated filer<br>Emerging growth company
SIC2835 In Vitro & In Vivo Diagnostic Substances
EIN000000000
LEI—
Fiscal year end0331
State of incorporationE9 Cayman Islands
Phone44 020 7788 7414
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Virax Biolabs (Cayman) Ltd (2021-12-27T05:00:00.000Z → 2021-12-27T05:00:00.000Z)
Business address
BIOCITY GLASGOW
BO'NESS ROAD, NEWHOUSE
LANARKSHIRE
X0
ML1 5UH
United Kingdom
Mailing address
BIOCITY GLASGOW
BO'NESS ROAD, NEWHOUSE
LANARKSHIRE
X0
ML1 5UH
United Kingdom

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

161 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 6-K 6-K 0001193125-26-466205 001-41440 261568030 34 24677
2026-11-13 6-K 6-K 0001193125-26-460710 001-41440 261552863 34 3014498
2026-10-29 6-K 6-K 0001193125-26-437018 001-41440 261497538 34 90186
2026-10-21 3 3 0001193125-26-427235 9926
2026-10-09 6-K 6-K 0001193125-26-419117 001-41440 261453060 34 29684
2026-09-10 424B3 424B3 0001193125-26-386697 333-297684 261369134 33 2114900
2026-09-04 6-K 6-K 0001193125-26-383683 001-41440 261362319 34 240325
2026-09-04 424B5 424B5 0001193125-26-383658 333-275893 261362226 33 49347
2026-09-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002878 333-297684 261360059 33 1902
2026-09-02 F-3/A F-3/A 0001193125-26-380474 333-297684 261356024 33 2243098
2026-08-26 6-K 6-K 0001193125-26-368710 001-41440 261323397 34 41746
2026-08-18 6-K 6-K 0001193125-26-354722 001-41440 261288439 34 23720
2026-07-31 6-K 6-K 0001193125-26-326851 001-41440 261225451 34 2789038
2026-07-24 F-3 F-3 0001193125-26-316130 333-297684 261201755 33 675398 1 1
2026-07-16 6-K 6-K 0001193125-26-305400 001-41440 261178690 34 151605
2026-07-10 6-K 6-K 0001193125-26-300880 001-41440 261168803 34 801158
2026-07-09 6-K 6-K 0001193125-26-299132 001-41440 261163980 34 82371
2026-07-06 20-F 20-F 0001193125-26-295158 001-41440 261153846 34 14883693 1 1
2026-06-24 6-K 6-K 0001193125-26-281196 001-41440 261116517 34 71123
2026-06-12 6-K 6-K 0001193125-26-268604 001-41440 261085104 34 41012
2026-05-26 6-K 6-K 0001193125-26-237882 001-41440 261015943 34 84655
2026-05-22 6-K 6-K 0001193125-26-236980 001-41440 261014216 34 2889385
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002143 005-94426 26984118 34 10794
2026-04-14 6-K 6-K 0001193125-26-153963 001-41440 26859273 34 149102
2026-04-10 6-K 6-K 0001193125-26-151292 001-41440 26855034 34 27904
2026-03-31 3 3 0001193125-26-134281 8531
2026-03-20 3 3 0000950130-26-000117 9050
2026-03-18 6-K 6-K 0001193125-26-114283 001-41440 26770339 34 67977
2026-03-18 3 3 0001193125-26-113908 10287
2026-03-18 3 3 0001193125-26-113909 8544
2026-03-18 3 3 0001193125-26-113905 3161
2026-03-18 3 3 0001193125-26-113915 3390
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001233 005-94426 26645075 34 10616
2026-01-30 6-K 6-K 0001193125-26-031750 001-41440 26583270 34 5437389
2025-12-31 424B3 424B3 0001193125-25-338385 333-292241 251617870 33 298731
2025-12-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003963 333-292241 251615639 33 1902
2025-12-29 CORRESP filename1.htm 0001193125-25-335379 20675
2025-12-18 F-3 F-3 0001193125-25-324805 333-292241 251583089 33 653370 1 1
2025-12-18 D xslFormDX01/primary_doc.xml 06b 0001193125-25-323885 021-567275 251581607 33 10877
2025-12-04 6-K 6-K 0001193125-25-308079 001-41440 251549453 34 1205263
2025-12-02 6-K 6-K 0001193125-25-305371 001-41440 251543763 34 1635884
2025-10-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-256667 005-94426 251430979 34 6517
2025-10-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-256666 005-94426 251430977 34 6457
2025-10-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-256646 005-94426 251430940 34 6374
2025-10-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-256640 005-94426 251430927 34 6329
2025-07-30 6-K 6-K 0000950170-25-100244 001-41440 251167184 34 28811
2025-07-02 20-F 20-F 0000950170-25-093260 001-41440 251102723 34 14605086 1 1
2025-06-13 6-K 6-K 0000950170-25-086224 001-41440 251046930 34 24858
2025-03-18 6-K 6-K 0000950170-25-040776 001-41440 25746545 34 39344
2025-03-13 6-K 6-K 0000950170-25-038350 001-41440 25733902 34 40536
2025-03-05 6-K 6-K 0000950170-25-033079 001-41440 25708876 34 39917
2025-02-25 6-K 6-K 0000950170-25-026073 001-41440 25659403 34 41242
2025-01-30 S-8 S-8 0000950170-25-011148 333-284607 25574423 33 493597
2024-12-23 6-K 6-K 0000950170-24-139294 001-41440 241570220 34 50537
2024-12-17 6-K 6-K 0000950170-24-136922 001-41440 241553732 34 53558
2024-12-10 6-K 6-K 0000950170-24-134762 001-41440 241537140 34 35798
2024-11-20 6-K 6-K 0000950170-24-129224 001-41440 241480301 34 1355528
2024-11-14 SC 13G/A armistice-vrax093024a1.htm 0001172661-24-005285 005-94426 241463659 34 90595
2024-10-31 6-K 6-K 0000950170-24-119254 001-41440 241412541 34 4357588
2024-10-23 6-K 6-K 0000950170-24-116493 001-41440 241387893 34 35718
2024-09-30 6-K 6-K 0000950170-24-110180 001-41440 241336966 34 118492
2024-09-30 424B5 424B5 0000950170-24-110179 333-275893 241336959 33 44951
2024-08-23 6-K 6-K 0000950170-24-100027 001-41440 241233623 34 584375
2024-08-23 424B5 424B5 0000950170-24-100026 333-275893 241233618 33 879015
2024-08-20 20-F 20-F 0000950170-24-099115 001-41440 241225470 34 13085989 1 1
2024-08-01 NT 20-F NT 20-F 0000950170-24-088958 001-41440 241164339 34 75902
2024-06-11 6-K 6-K 0000950170-24-071955 001-41440 241036190 34 25401
2024-04-25 6-K 6-K 0000950170-24-047931 001-41440 24873074 34 44820
2024-04-16 6-K 6-K 0000950170-24-044600 001-41440 24846111 34 37135
2024-03-15 6-K 6-K 0000950170-24-032238 001-41440 24755331 34 41663
2024-02-14 SC 13G armistice-vrax123123.htm 0001172661-24-001412 005-94426 24637232 34 90468
2024-01-22 6-K 6-K 0000950170-24-006158 001-41440 24549916 34 455117
2024-01-22 424B5 424B5 0000950170-24-006155 333-275893 24549910 33 822625
2024-01-12 6-K 6-K 0000950170-24-004110 001-41440 24530592 34 1222739
2023-12-21 6-K 6-K 0000950170-23-072054 001-41440 231502781 34 44668
2023-12-20 424B3 424B3 0000950170-23-071887 333-275893 231501463 33 80562
2023-12-20 6-K 6-K 0000950170-23-071878 001-41440 231501387 34 694112
2023-12-20 424B3 424B3 0000950170-23-071872 333-275893 231501352 33 432408
2023-12-18 6-K 6-K 0000950170-23-070939 001-41440 231492243 34 50599
2023-12-15 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2023-12-15 16:00:00 9999999995-23-003660 333-275893 231492117 33 1835
2023-12-14 6-K 6-K 0000950170-23-070211 001-41440 231485570 34 44335
2023-12-13 CORRESP filename1.htm 0000950170-23-069895 18565
2023-12-12 UPLOAD filename1.pdf 0000000000-23-013499 40347
2023-12-08 6-K 6-K 0000950170-23-068915 001-41440 231473855 34 52228
2023-12-05 F-3 F-3 0000950170-23-068150 333-275893 231466583 33 6172039
2023-11-08 6-K 6-K 0000950170-23-061115 001-41440 231387946 34 2782313
2023-10-31 6-K 6-K 0000950170-23-056917 001-41440 231365224 34 68155
2023-10-17 D xslFormDX01/primary_doc.xml 06b 0001209191-23-052944 021-495026 231329652 33 12431
2023-10-12 6-K 6-K 0000950170-23-053005 001-41440 231321731 34 341662
2023-10-04 6-K 6-K 0000950170-23-051791 001-41440 231306571 34 35955
2023-09-12 6-K 6-K 0000950170-23-047593 001-41440 231249038 34 50899
2023-09-01 6-K 6-K 0000950170-23-045918 001-41440 231230626 34 328776
2023-08-03 6-K 6-K 0000950170-23-037619 001-41440 231138263 34 55012
2023-07-18 6-K 6-K 0000950170-23-033260 001-41440 231093020 34 63276
2023-06-14 20-F 20-F 0000950170-23-027973 001-41440 231014551 34 12144954 1 1
2023-06-14 6-K 6-K 0000950170-23-027851 001-41440 231013024 34 95142
2023-05-04 6-K 6-K 0000950170-23-017479 001-41440 23886588 34 68449
2023-04-21 6-K 6-K 0000950170-23-013864 001-41440 23836775 34 56005
2023-04-19 6-K 6-K 0000950170-23-013366 001-41440 23828537 34 56777
2023-03-31 424B3 424B3 0000950170-23-011363 333-270734 23787481 33 531326
2023-03-30 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2023-03-30 17:00:00 9999999995-23-000763 333-270734 23782895 33 1785
2023-03-28 CORRESP filename1.htm 0000950170-23-010319 25621
2023-03-28 UPLOAD filename1.pdf 0000000000-23-003057 40296
2023-03-22 F-1 f-1_march_2023_pipe.htm 0000950123-23-002979 333-270734 23751630 33 1017671
2023-03-15 D xslFormDX01/primary_doc.xml 06b 0001209191-23-018884 021-475980 23735347 33 12988
2023-03-10 6-K 6-K 0000950170-23-007361 001-41440 23724871 34 1552011
2023-03-07 6-K 6-K 0000950170-23-006381 001-41440 23711056 34 58725
2023-02-07 6-K 6-K 0000950170-23-001922 001-41440 23592903 34 60228
2023-02-02 6-K 6-K 0000950170-23-001708 001-41440 23581329 34 1163635
2023-02-02 6-K 6-K 0000950170-23-001639 001-41440 23578806 34 74678
2023-01-04 6-K 6-K 0000950170-23-000093 001-41440 23504365 34 55754
2022-12-06 6-K 6-K 0000950170-22-026062 001-41440 221446708 34 57096
2022-12-02 424B3 424B3 0000950170-22-026001 333-268486 221442158 33 506807
2022-12-01 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2022-12-01 16:00:00 9999999995-22-003433 333-268486 221440189 33 1729
2022-11-29 CORRESP filename1.htm 0000950170-22-025776 20566
2022-11-25 UPLOAD filename1.pdf 0000000000-22-012751 40233
2022-11-21 F-1 F-1 0001193125-22-289176 333-268486 221402988 33 559177
2022-11-18 6-K 6-K 0000950170-22-025459 001-41440 221402868 34 159500
2022-11-15 6-K 6-K 0000950170-22-025152 001-41440 221389409 34 57775
2022-11-08 6-K 6-K 0000950170-22-023305 001-41440 221369716 34 1033513
2022-11-03 6-K 6-K 0000950170-22-021570 001-41440 221356341 34 59390
2022-10-26 6-K 6-K 0000950170-22-020103 001-41440 221331123 34 61153
2022-09-22 6-K 6-K 0000950170-22-018742 001-41440 221257885 34 60320
2022-09-20 6-K 6-K 0000950170-22-018651 001-41440 221252096 34 57160
2022-09-12 6-K 6-K 0000950170-22-018317 001-41440 221237404 34 60728
2022-09-07 6-K 6-K 0000950170-22-018162 001-41440 221230084 34 58912
2022-08-12 20-F 20-F 0000950170-22-017130 001-41440 221160418 34 14002312 1 1
2022-07-29 NT 20-F NT 20-F 0000950170-22-013497 001-41440 221120686 34 78789
2022-07-29 6-K 6-K 0000950170-22-013443 001-41440 221117674 34 25116
2022-07-26 6-K 6-K 0000950170-22-013034 001-41440 221104918 34 1272840
2022-07-21 424B4 PROSPECTUS 0001213900-22-040585 333-263694 221095808 33 17909135
2022-07-20 CERT 8A_Cert_VRAX.pdf 0001354457-22-000418 001-41440 221094669 34 186245
2022-07-01 FWP FREE WRITING PROSPECTUS 0001213900-22-036411 333-263694 221059321 34 5221909
2022-06-30 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2022-06-30 09:00:00 9999999995-22-001935 333-263694 221059454 33 1729
2022-06-30 FWP FREE WRITING PROSPECTUS 0001213900-22-036185 333-263694 221057352 34 5236854
2022-06-30 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-22-036073 001-41440 221056653 34 15607
2022-06-28 CORRESP filename1.htm 0001213900-22-035397 5583
2022-06-28 CORRESP filename1.htm 0001213900-22-035396 6585
2022-06-27 F-1/A REGISTRATION STATEMENT 0001213900-22-035012 333-263694 221041458 33 18317597
2022-06-24 CORRESP filename1.htm 0001213900-22-035014 7348
2022-06-24 UPLOAD filename1.pdf 0000000000-22-006839 43281
2022-06-24 CORRESP filename1.htm 0001213900-22-034731 16284
2022-06-24 F-1/A REGISTRATION STATEMENT 0001213900-22-034730 333-263694 221037074 33 18316818
2022-06-23 UPLOAD filename1.pdf 0000000000-22-006778 45414
2022-06-21 CORRESP filename1.htm 0001213900-22-033731 13071
2022-06-21 F-1/A AMENDMENT NO. 4 TO FORM F-1 0001213900-22-033728 333-263694 221025941 33 19833557
2022-06-16 UPLOAD filename1.pdf 0000000000-22-006565 47011
2022-06-07 F-1/A REGISTRATION STATEMENT 0001213900-22-031420 333-263694 22999242 33 18394648
2022-05-11 CORRESP filename1.htm 0001213900-22-025541 11727
2022-05-11 F-1/A REGISTRATION STATEMENT 0001213900-22-025539 333-263694 22913316 33 18343344
2022-05-05 UPLOAD filename1.pdf 0000000000-22-004955 45959
2022-04-25 F-1/A REGISTRATION STATEMENT 0001213900-22-021214 333-263694 22846918 33 24185463
2022-04-22 CORRESP filename1.htm 0001213900-22-021221 110480
2022-04-07 UPLOAD filename1.pdf 0000000000-22-003729 73722
2022-03-18 CORRESP filename1.htm 0001213900-22-013573 33223
2022-03-18 F-1 REGISTRATION STATEMENT 0001213900-22-013563 333-263694 22752386 33 26414043
2022-03-10 UPLOAD filename1.pdf 0000000000-22-002645 62236
2022-02-17 DRSLTR filename1.htm 0001213900-22-008213 61134
2022-02-17 DRS/A filename1.htm 0001213900-22-008211 377-05887 22646789 33 23882764
2022-01-28 UPLOAD filename1.pdf 0000000000-22-001184 82787
2021-12-27 DRS filename1.htm 0001213900-21-067581 377-05887 211521098 33 13448830

Latest XBRL company facts

One latest value per concept from companyfacts (128 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 579,218 2026-03-31 2026 FY 20-F 2026-07-06 0001193125-26-295158
ffd NetFeeAmt NetFeeAmt USD 1,401.95 2026-07-23 F-3 2026-07-24 0001193125-26-316130
ffd TtlFeeAmt TtlFeeAmt USD 1,401.95 2026-07-23 F-3 2026-07-24 0001193125-26-316130
ffd TtlOfferingAmt TtlOfferingAmt USD 10.15M 2026-07-23 F-3 2026-07-24 0001193125-26-316130
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-23 F-3 2026-07-24 0001193125-26-316130
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-23 F-3 2026-07-24 0001193125-26-316130
ifrs-full AccumulatedOtherComprehensiveIncome AccumulatedOtherComprehensiveIncome USD 112,330 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill USD 211,952 2023-04-01 2024-03-31 2024 FY 20-F 2024-08-20 0000950170-24-099115
ifrs-full AdditionsToRightofuseAssets AdditionsToRightofuseAssets USD 181,641 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustedWeightedAverageShares AdjustedWeightedAverageShares shares 3.73M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustmentsForDecreaseIncreaseInInventories AdjustmentsForDecreaseIncreaseInInventories USD -34,292 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustmentsForDecreaseIncreaseInLoansAndAdvances AdjustmentsForDecreaseIncreaseInLoansAndAdvances USD 32,468 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustmentsForDecreaseIncreaseInPrepaidExpenses AdjustmentsForDecreaseIncreaseInPrepaidExpenses USD -26,600 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustmentsForDecreaseIncreaseInTradeAccountReceivable AdjustmentsForDecreaseIncreaseInTradeAccountReceivable USD 337,576 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities USD -38,250 2023-04-01 2024-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustmentsForIncreaseDecreaseInTradeAccountPayable AdjustmentsForIncreaseDecreaseInTradeAccountPayable USD 129,276 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustmentsForInterestExpense AdjustmentsForInterestExpense USD 5,986 2021-04-01 2022-03-31 2023 FY 20-F 2023-06-14 0000950170-23-027973
ifrs-full AdjustmentsForSharebasedPayments AdjustmentsForSharebasedPayments USD 365,309 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AdjustmentsForUnrealisedForeignExchangeLossesGains AdjustmentsForUnrealisedForeignExchangeLossesGains USD 123,743 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full AmountsPayableRelatedPartyTransactions AmountsPayableRelatedPartyTransactions USD 337,576 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full Assets Assets USD 6.43M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full BalancesWithBanks BalancesWithBanks USD 9.35M 2023-03-31 2023 FY 20-F 2023-06-14 0000950170-23-027973
ifrs-full BasicEarningsLossPerShare BasicEarningsLossPerShare USD/shares -1.62 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full Borrowings Borrowings USD 315,000 2024-07-01 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full BorrowingsInterestRate BorrowingsInterestRate pure 0.082 2024-07-01 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CapitalReserve CapitalReserve USD 30.17M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full Cash Cash USD 4.23M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CashAdvancesAndLoansFromRelatedParties CashAdvancesAndLoansFromRelatedParties USD -18,296 2023-04-01 2024-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CashAndCashEquivalents CashAndCashEquivalents USD 4.23M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CashEquivalents CashEquivalents USD 0 2023-03-31 2023 FY 20-F 2023-06-14 0000950170-23-027973
ifrs-full CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities USD 5.81M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CashFlowsFromUsedInInvestingActivities CashFlowsFromUsedInInvestingActivities USD -603,890 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities USD -4.56M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CashOutflowForLeases CashOutflowForLeases GBP 101,489 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ComprehensiveIncome ComprehensiveIncome USD -5.96M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ComprehensiveIncomeAttributableToNoncontrollingInterests ComprehensiveIncomeAttributableToNoncontrollingInterests USD -5,985 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ComprehensiveIncomeAttributableToOwnersOfParent ComprehensiveIncomeAttributableToOwnersOfParent USD -5.95M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ContractLiabilities ContractLiabilities USD 0 2024-03-31 2024 FY 20-F 2024-08-20 0000950170-24-099115
ifrs-full CostOfInventoriesRecognisedAsExpenseDuringPeriod CostOfInventoriesRecognisedAsExpenseDuringPeriod USD 59,398 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CostOfSales CostOfSales USD 59,398 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CurrentAssets CurrentAssets USD 4.89M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CurrentDebtInstrumentsIssued CurrentDebtInstrumentsIssued USD 32,468 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CurrentLeaseLiabilities CurrentLeaseLiabilities USD 52,993 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CurrentLiabilities CurrentLiabilities USD 673,207 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full CurrentTradeReceivables CurrentTradeReceivables USD 928 2021-03-31 2022 FY 20-F 2022-08-12 0000950170-22-017130
ifrs-full CurrentValueAddedTaxReceivables CurrentValueAddedTaxReceivables USD 30,654 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full DeferredIncomeIncludingContractLiabilities DeferredIncomeIncludingContractLiabilities USD 38,250 2023-03-31 2024 FY 20-F 2024-08-20 0000950170-24-099115
ifrs-full DeferredTaxAssets DeferredTaxAssets USD 1.30M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full DepreciationAndAmortisationExpense DepreciationAndAmortisationExpense USD 266,601 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full DepreciationExpense DepreciationExpense USD 266,601 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full DescriptionOfOptionLifeShareOptionsGranted DescriptionOfOptionLifeShareOptionsGranted Y 5 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full DilutedEarningsLossPerShare DilutedEarningsLossPerShare USD/shares -1.62 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares shares 0 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full EmployeeBenefitsExpense EmployeeBenefitsExpense USD 365,309 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full Equity Equity USD 5.46M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full EquityAndLiabilities EquityAndLiabilities USD 6.43M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full EquityAttributableToOwnersOfParent EquityAttributableToOwnersOfParent USD 5.70M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ExercisePriceShareOptionsGranted2019 ExercisePriceShareOptionsGranted2019 USD/shares 0.68 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full FinishedGoods FinishedGoods USD 46,904 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full GeneralAndAdministrativeExpense GeneralAndAdministrativeExpense USD 4.33M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full GrossProfit GrossProfit USD -53,067 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill USD 0 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill USD 390,355 2023-04-01 2024-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full IncomeTaxExpenseContinuingOperations IncomeTaxExpenseContinuingOperations USD -136,661 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full IncreaseDecreaseInCashAndCashEquivalents IncreaseDecreaseInCashAndCashEquivalents USD 639,700 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full IncreaseDecreaseThroughConversionOfConvertibleInstruments IncreaseDecreaseThroughConversionOfConvertibleInstruments USD 99,999 2021-04-01 2022-03-31 2024 FY 20-F 2024-08-20 0000950170-24-099115
ifrs-full IncreaseDecreaseThroughExerciseOfWarrantsEquity IncreaseDecreaseThroughExerciseOfWarrantsEquity USD 786,736 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full IncreaseDecreaseThroughOtherDistributionsToOwners IncreaseDecreaseThroughOtherDistributionsToOwners USD 25,000 2020-04-01 2021-03-31 2022 FY 20-F 2022-08-12 0000950170-22-017130
ifrs-full IncreaseDecreaseThroughTransferToStatutoryReserve IncreaseDecreaseThroughTransferToStatutoryReserve USD 21,128 2021-04-01 2022-03-31 2024 FY 20-F 2024-08-20 0000950170-24-099115
ifrs-full IntangibleAssetsAndGoodwill IntangibleAssetsAndGoodwill USD 178,403 2023-03-31 2024 FY 20-F 2024-08-20 0000950170-24-099115
ifrs-full IntangibleAssetsOtherThanGoodwill IntangibleAssetsOtherThanGoodwill USD 178,403 2023-03-31 2024 FY 20-F 2024-08-20 0000950170-24-099115
ifrs-full InterestExpenseOnBorrowings InterestExpenseOnBorrowings USD 11,666 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full InterestExpenseOnDebtInstrumentsIssued InterestExpenseOnDebtInstrumentsIssued USD 21,128 2021-04-01 2022-03-31 2024 FY 20-F 2024-08-20 0000950170-24-099115
ifrs-full InterestExpenseOnLeaseLiabilities InterestExpenseOnLeaseLiabilities USD 45,600 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full InterestPaidClassifiedAsOperatingActivities InterestPaidClassifiedAsOperatingActivities USD -78,953 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full InterestRevenueExpense InterestRevenueExpense USD 58,179 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full Inventories Inventories USD 94,675 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full InventoryWritedown2011 InventoryWritedown2011 USD 46,904 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full IssuedCapital IssuedCapital USD 4,342 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full IssueOfEquity IssueOfEquity USD 5.13M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full KeyManagementPersonnelCompensationSharebasedPayment KeyManagementPersonnelCompensationSharebasedPayment USD 0 2021-04-01 2022-03-31 2022 FY 20-F 2022-08-12 0000950170-22-017130
ifrs-full LeaseLiabilities LeaseLiabilities USD 344,536 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full Liabilities Liabilities USD 964,750 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full MaximumExposureToCreditRisk MaximumExposureToCreditRisk USD 4.23M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NoncontrollingInterests NoncontrollingInterests USD -233,967 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NoncurrentAssets NoncurrentAssets USD 1.53M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NoncurrentLeaseLiabilities NoncurrentLeaseLiabilities USD 291,543 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NoncurrentTradeReceivables NoncurrentTradeReceivables USD 928 2021-03-31 2022 FY 20-F 2022-08-12 0000950170-22-017130
ifrs-full NumberOfOutstandingShareOptions NumberOfOutstandingShareOptions shares 417,332 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NumberOfShareOptionsExercisableInSharebasedPaymentArrangement NumberOfShareOptionsExercisableInSharebasedPaymentArrangement shares 87,372 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NumberOfShareOptionsExpiredInSharebasedPaymentArrangement NumberOfShareOptionsExpiredInSharebasedPaymentArrangement shares 8,433 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement shares 29,435 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NumberOfShareOptionsGrantedInSharebasedPaymentArrangement NumberOfShareOptionsGrantedInSharebasedPaymentArrangement shares 0 2021-04-01 2022-03-31 2023 FY 20-F 2023-06-14 0000950170-23-027973
ifrs-full NumberOfSharesAuthorised NumberOfSharesAuthorised shares 50.00M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NumberOfSharesIssued NumberOfSharesIssued shares 4.34M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full NumberOfSharesOutstanding NumberOfSharesOutstanding shares 4.34M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full OperatingExpense OperatingExpense USD 6.11M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation USD 110,379 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ParValuePerShare ParValuePerShare USD/shares 0.001 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities USD 107,756 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full PercentageOfEntitysRevenue PercentageOfEntitysRevenue pure 1 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full PercentageOfVotingEquityInterestsAcquired PercentageOfVotingEquityInterestsAcquired pure 0.957 2021-06-24 2022 FY 20-F 2022-08-12 0000950170-22-017130
ifrs-full ProceedsFromExerciseOfWarrants ProceedsFromExerciseOfWarrants USD 786,736 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ProceedsFromIssuingShares ProceedsFromIssuingShares USD 5.13M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ProfitLoss ProfitLoss USD -6.07M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ProfitLossAttributableToNoncontrollingInterests ProfitLossAttributableToNoncontrollingInterests USD -5,985 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ProfitLossAttributableToOwnersOfParent ProfitLossAttributableToOwnersOfParent USD -6.06M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ProfitLossBeforeTax ProfitLossBeforeTax USD -6.20M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities USD -6.16M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full PropertyPlantAndEquipment PropertyPlantAndEquipment USD 1.23M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities USD 178,403 2022-04-01 2023-03-31 2023 FY 20-F 2023-06-14 0000950170-23-027973
ifrs-full PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities USD 603,890 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full RawMaterials RawMaterials USD 49,956 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full ResearchAndDevelopmentExpense ResearchAndDevelopmentExpense USD 1.78M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full RetainedEarnings RetainedEarnings USD -24.59M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full RevenueFromContractsWithCustomers RevenueFromContractsWithCustomers USD 6,331 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full RightofuseAssets RightofuseAssets USD 306,652 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full SellingExpense SellingExpense USD 26,616 2022-04-01 2023-03-31 2023 FY 20-F 2023-06-14 0000950170-23-027973
ifrs-full TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss USD -115,279 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full TaxEffectOfForeignTaxRates TaxEffectOfForeignTaxRates USD 65,781 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full TradeAndOtherCurrentPayablesToRelatedParties TradeAndOtherCurrentPayablesToRelatedParties USD 337,576 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full TradeAndOtherCurrentPayablesToTradeSuppliers TradeAndOtherCurrentPayablesToTradeSuppliers USD 56,093 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full TradeReceivables TradeReceivables USD 928 2021-03-31 2022 FY 20-F 2022-08-12 0000950170-22-017130
ifrs-full UndiscountedOperatingLeasePaymentsToBeReceived UndiscountedOperatingLeasePaymentsToBeReceived USD 470,036 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised USD 1.30M 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full WeightedAverageFairValueAtMeasurementDateShareOptionsGranted WeightedAverageFairValueAtMeasurementDateShareOptionsGranted USD 0.67 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full WeightedAverageShares WeightedAverageShares shares 3.73M 2024-04-01 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260
ifrs-full WorkInProgress WorkInProgress USD 44,719 2025-03-31 2025 FY 20-F 2025-07-02 0000950170-25-093260

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →